Search

everythinglearnresearchcommunity

for

Search:↓

Certolizumab effectively treats psoriasis and psoriatic arthritis with fewer side effects than adalimumab.

Switching from adalimumab to ixekizumab improved a patient's psoriasis and reversed hair whitening.

Tofacitinib successfully treated vitiligo in a patient with lupus without side effects.

Alitretinoin may help treat alopecia areata.

A humanized IL-2 fusion protein boosts T regulatory cells and helps control hair loss in Alopecia Areata.

Ritlecitinib is cost-effective for severe alopecia areata in Japan.

A 50 mg non-loading dose of ritlecitinib is safe for adults and adolescents.

Ruxolitinib cream shows promise for vitiligo, and early melanoma diagnosis is crucial.

Alternative treatments are needed when Tofacitinib alone fails for alopecia areata.

Clofazimine effectively treated ashy dermatosis in a patient.

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

Selective immunotherapies like anifrolumab and belimumab are more effective for treating systemic lupus erythematosus than traditional drugs.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

Upadacitinib significantly improved both rheumatoid arthritis and alopecia areata in a patient.

Ixekizumab is effective and safe for patients who did not improve with etanercept treatment for psoriasis.

A 29-year-old woman with symptoms of both lupus and rheumatoid arthritis improved with specific medications.

Telitacicept helped stabilize complement levels in a patient with lupus and thyroid cancer.

Leflunomide and methotrexate are similarly effective for rheumatoid arthritis but have different side effects.

A woman with advanced eye cancer went into complete remission using a combination of immunotherapy and topical treatments.

Previous alopecia areata treatments do not affect the long-term effectiveness of ritlecitinib.

Topical ruxolitinib cream may help treat frontal fibrosing alopecia.

The rash resolved after stopping ponatinib.

BMD-1141 effectively regrows hair in alopecia areata with less frequent dosing than current treatments.

Low-dose Ritlecitinib may help children with stubborn Alopecia Areata.

The muscle damage was caused by T-cell large granular lymphocytic leukemia, not dermatomyositis.

Ritlecitinib is approved in the USA and Japan for treating severe hair loss in people aged 12 and older.

Trastuzumab deruxtecan is effective for HER2-positive breast cancer but requires careful management of side effects.